Paysign director Henry buys $50,000 in common stock

Published 17/06/2025, 02:04
Paysign director Henry buys $50,000 in common stock

HENDERSON, NV—Daniel R. Henry, a director at Paysign, Inc. (NASDAQ:PAYS), has recently acquired a significant amount of the company’s common stock. According to a filing with the Securities and Exchange Commission, Henry purchased 10,084 shares on June 16, 2025. The shares were bought at a weighted average price of $4.9583, with the transaction totaling approximately $50,000. The purchase comes as Paysign shares have shown remarkable strength, with a 65% gain over the past six months and the stock currently trading at $5.12.

The acquisition boosts Henry’s direct ownership in Paysign to 129,884 shares. The purchase was executed through multiple transactions at prices ranging from $4.9385 to $4.99 per share. According to InvestingPro data, the company, currently valued at $278 million, is trading near its Fair Value, with analysts projecting profit growth this year. This move signals Henry’s continued confidence in the company’s prospects and aligns with his role as a director.[Get access to 10+ additional ProTips and comprehensive analysis for Paysign and 1,400+ stocks with InvestingPro]

In other recent news, Paysign Inc. reported impressive first-quarter earnings for 2025, with a significant 41% increase in total revenue, reaching $18.6 million. The company’s earnings per share (EPS) of $0.05 far exceeded the forecast of $0.01, showcasing a robust financial performance. DA Davidson responded to these results by raising its price target for Paysign to $6.00, maintaining a Buy rating, and highlighting the company’s strong quarterly report. Additionally, Paysign announced an expansion in its plasma donation center network, adding 132 centers, which will increase its total to 615 centers and boost its U.S. market share to approximately 50%.

This expansion is expected to drive immediate revenue growth without increasing Selling, General and Administrative (SG&A) expenses, demonstrating the company’s operating leverage. DA Davidson further raised its price target to $8.00, citing Paysign’s expansion in the plasma industry as a key factor for raising financial forecasts for 2025 and 2026. During its annual stockholders meeting, Paysign elected all seven nominees to the Board of Directors and approved executive compensation measures. The company also ratified Moss Adams LLP as its independent auditor for the fiscal year 2025. These developments reflect Paysign’s strategic efforts to enhance its market position and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.